SURROZEN
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.
SURROZEN
Industry:
Biotechnology Emergency Medicine Health Care
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.surrozen.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
253 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Font Awesome IPv6 JsDelivr Cloudflare JS CDN JS AJAX Libraries API BootstrapCDN
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
The Column Group
The Column Group investment in Post-IPO Equity - Surrozen
Consonance Capital Partners
Consonance Capital Partners investment in Post-IPO Equity - Surrozen
Euclidean Capital
Euclidean Capital investment in Series C - Surrozen
Horizons Ventures
Horizons Ventures investment in Series C - Surrozen
The Column Group
The Column Group investment in Series C - Surrozen
Horizons Ventures
Horizons Ventures investment in Series B - Surrozen
The Column Group
The Column Group investment in Series B - Surrozen
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series B - Surrozen
NS Investment
NS Investment investment in Series B - Surrozen
The Column Group
The Column Group investment in Series A - Surrozen
Official Site Inspections
http://www.surrozen.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.72 K
- Host name: a20b9ee60132ef283.awsglobalaccelerator.com
- IP address: 13.248.155.104
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
